How does a child acquire herpes simplex virus (HSV) that can lead to erythema multiforme?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Children Acquire HSV Leading to Erythema Multiforme

Children most commonly acquire HSV through direct contact with infected oral secretions or lesions from family members or caregivers, with HSV-1 being the predominant cause of both primary infection and subsequent HSV-associated erythema multiforme in the pediatric population 1, 2.

Primary Routes of HSV Acquisition in Children

Non-Neonatal Transmission (Most Common)

  • Direct contact with infected oral secretions or lesions from adults or other children 1
  • Primary HSV-1 infection typically manifests as gingivostomatitis with fever, irritability, tender submandibular lymphadenopathy, and painful oral/perioral ulcers 1
  • The virus establishes latency in sensory ganglia (cervical ganglia for oral HSV) and can reactivate later 2, 3

Neonatal Transmission (Less Common for EM)

  • Exposure to HSV-infected maternal genital fluids during vaginal delivery 1
  • Risk is highest (30-50%) when mother has primary HSV infection at delivery 1
  • Much lower risk (0-5%) with maternal reactivated infection 1
  • Ascending infection or invasive procedures (fetal scalp monitoring) during labor 1
  • Neonatal infection rate: 1 per 2,000-5,000 deliveries 1

The HSV-to-Erythema Multiforme Connection

HSV is the most significant precipitating factor for erythema multiforme in children, even when there is no obvious clinical history of herpes infection 4, 5.

Key Clinical Pattern

  • Mean time from HSV lesion to EM onset: 3.9 days (range 0-11 days) 4
  • Preceding HSV manifestations include:
    • Herpes labialis (most common - 67% of cases) 4
    • Herpes facialis 4
    • Some children have no obvious HSV lesion but still have HSV DNA detectable in EM target lesions 4, 5

Evidence of HSV Causation

Research demonstrates that HSV DNA is present in EM skin lesions in 80% of children with both "herpes-associated" and "idiopathic" EM 5. This means:

  • Even children without a known history of herpes infection likely have HSV as the trigger 5
  • HSV DNA detected by polymerase chain reaction (PCR) in target lesions confirms the association 4, 5
  • The virus localizes to the epidermis within the EM lesions 5

Important Clinical Distinctions

EM vs. Stevens-Johnson Syndrome

Erythema multiforme is distinct from SJS/TEN and does not progress to these more severe conditions 6. Key differences:

  • EM typically precipitated by infection (especially HSV), while SJS/TEN usually caused by drugs 6
  • EM characterized by typical target lesions starting on acral surfaces progressing proximally 6
  • EM patients are constitutionally well, make good recovery, rarely have long-term complications 6
  • Mucosal involvement in EM major (EMM) usually confined to mouth 6

Recurrence Pattern

  • Mean age at EM onset: 8.1 years 4
  • In 75% of pediatric cases, EM is recurrent with mean of 2.6 episodes per year 4
  • Recurrence more common in children than adults because precipitant is usually infection (which recurs) rather than drugs (which can be avoided) 6
  • Recurrences can be triggered by sun exposure 4

Clinical Pitfalls to Avoid

  1. Don't dismiss EM as non-HSV-related just because there's no obvious herpes history - 80% of "idiopathic" EM cases in children still have HSV DNA in lesions 5

  2. Don't confuse EM with SJS/TEN - they require different management approaches and have different prognoses 6

  3. Don't expect acute antiviral treatment to shorten individual EM episodes - oral acyclovir at 25 mg/kg/day does not reduce episode duration 4

  4. Consider prophylactic antivirals for frequent recurrences - 6-month prophylaxis with oral acyclovir at 20 mg/kg/day can prevent recurrences during treatment 4, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.